• New tool predicts changes that may make

    From ScienceDaily@1:317/3 to All on Wed Sep 29 21:30:52 2021
    New tool predicts changes that may make COVID variants more infectious


    Date:
    September 29, 2021
    Source:
    Penn State
    Summary:
    Researchers have created a novel framework that can predict
    with reasonable accuracy the amino-acid changes in the virus'
    spike protein that may improve its binding to human cells and
    confer increased infectivity to the virus. The tool could enable
    the computational surveillance of SARS-CoV-2 and provide advance
    warning of potentially dangerous variants with an even higher
    binding affinity potential. This can aid in the early implementation
    of public health measures to prevent the virus's spread and perhaps
    even may inform vaccine booster formulations.



    FULL STORY ==========================================================================
    As SARS-CoV-2 continues to evolve, new variants are expected to arise that
    may have an increased ability to infect their hosts and evade the hosts'
    immune systems. The first key step in infection is when the virus' spike protein binds to the ACE2 receptor on human cells. Researchers at Penn
    State have created a novel framework that can predict with reasonable
    accuracy the amino-acid changes in the virus' spike protein that may
    improve its binding to human cells and confer increased infectivity to
    the virus.


    ==========================================================================
    The tool could enable the computational surveillance of SARS-CoV-2
    and provide advance warning of potentially dangerous variants with
    an even higher binding affinity potential. This can aid in the early implementation of public health measures to prevent the virus's spread
    and perhaps even may inform vaccine booster formulations.

    "Emerging variants could potentially be highly contagious in humans and
    other animals," said Suresh Kuchipudi, clinical professor of veterinary
    and biomedical sciences and associate director of the Animal Diagnostic
    Lab, Penn State. "Therefore, it is critical to proactively assess
    what amino acid changes may likely increase the infectiousness of the
    virus. Our framework is a powerful tool for determining the impact of
    amino acid changes in the SARS-CoV- 2 spike protein that affect the
    ability of the virus to bind to ACE2 receptors in humans and multiple
    animal species." The team used a novel, two-step computational procedure
    to create a model for predicting which changes in amino acids -- molecules linked together to form proteins -- may occur in the receptor binding
    domain (RBD) of SARS-CoV-2's spike protein that could affect its ability
    to bind to the ACE2 receptors of human and other animal cells.

    According to Kuchipudi, the currently circulating variants include one
    or more mutations that have led to amino-acid changes in the RBD of the
    spike protein.

    "These amino-acid changes may have conferred fitness advantages
    and increased infectivity through a variety of mechanisms," he
    said. "Increased binding affinity of the RBD of the spike protein with
    the human ACE2 receptor is one such mechanism." Kuchipudi explained
    that the spike protein binding to the ACE2 receptor is the first and
    crucial step in viral entry to the cell.



    ==========================================================================
    "The binding strength between RBD and ACE2 directly affects infection
    dynamics and potentially disease progression," he said. "The ability to reliably predict the effects of virus amino-acid changes in the ability
    of its RBD to interact more strongly with the ACE2 receptor can help in assessing public health implications and the potential for spillover and adaptation into humans and other animals." Costas D. Maranas, Donald
    B. Broughton Professor in the Department of Chemical Engineering at Penn
    State, led the development of the team's new two-step procedure. First,
    the researchers tested the predictive power of a technique, called
    Molecular Mechanics-Generalized Born Surface Area (MM-GBSA) analysis, to quantify the binding affinity of the RBD for ACE2. MM-GBSA analysis sums
    up multiple types of energy contributions associated with the virus's RBD "sticking" to the human ACE2 receptor. Using data from already existing variants, the team found that this technique was only partially able to
    predict the binding affinity of SARS-CoV-2's RBD for ACE2.

    Therefore, Maranas and the team explored the use of the energy terms
    from the MM-GBSA analysis as features in a neural network regression
    model -- a type of deep-learning algorithm -- and trained the model
    using experimentally available data on binding in variants with single
    amino acid changes. They found that they could predict with more than 80% accuracy whether certain amino acid changes improved or worsened binding affinity for the dataset explored.

    "This combined MM-GBSA with a neural network model approach appears to
    be quite effective at predicting the effect of amino acid changes not
    used during model training," said Maranas.

    The model also allowed for the prediction of the binding strength
    of various already observed SARS-CoV-2 amino acid changes seen in
    the Alpha, Beta, Gamma and Delta variants. This may provide the
    computational means for predicting such affinities in yet-to-be
    discovered variants. Nevertheless, even though our computational tool
    can find amino acid changes that boost binding affinity even further,
    they have not yet been observed in circulating variants. This may mean
    that such changes could interfere with other requirements of productive
    virus infection. It is a reminder that binding with the ACE2 receptor
    is not the complete story.



    ==========================================================================
    The findings published today (Sept. 29) in the journal Proceedings of
    the National Academy of Sciences.

    "Our method sets up a framework for screening for binding affinity
    changes resulting from unknown single and multiple amino acid changes; therefore, offering a valuable tool to assess currently circulating and prospectively future viral variants in terms of their affinity for ACE2
    and greater infectiousness," said Maranas.

    Kuchipudi added, "SARS-CoV-2 can switch hosts as a result of increased
    contact between the virus and potential new hosts. This tool can help
    make sense of the enormous virus sequence data generated by genomic surveillance. In particular, it may help determine if the virus can
    adapt and spread among agricultural animals, thereby informing targeted mitigation measures." Co-first authors on the paper are Chen Chen, postdoctoral researcher, and Veda Sheersh Boorla, graduate student in
    chemical engineering, both at Penn State.

    Other authors include Deepro Banerjee, graduate research assistant, Penn
    State; Ratul Chowdhury, postodoctoral associate, Harvard University;
    Victoria S.

    Cavener, researcher, Huck Institutes of the Life Sciences, Penn State;
    Ruth H.

    Nissly, research technologist in veterinary and biomedical sciences,
    Penn State; Abhinay Gontu, graduate student in veterinary and biomedical sciences, Penn State; Nina R. Boyle, graduate student in integrative and biomedical physiology, Penn State; Kurt Vandegrift, associate research professor of biology, Penn State; and Meera Surendran Nair, assistant
    clinical professor of veterinary and biomedical sciences, Penn State.

    The United States Department of Agriculture, the United States Department
    of Energy and the Huck Institutes of the Life Sciences at Penn State
    supported this research.

    ========================================================================== Story Source: Materials provided by Penn_State. Original written by Sara LaJeunesse. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, Ratul Chowdhury,
    Victoria S. Cavener, Ruth H. Nissly, Abhinay Gontu, Nina R. Boyle,
    Kurt Vandegrift, Meera Surendran Nair, Suresh V. Kuchipudi, Costas
    D. Maranas.

    Computational prediction of the effect of amino acid changes
    on the binding affinity between SARS-CoV-2 spike RBD and human
    ACE2. Proceedings of the National Academy of Sciences, 2021; 118
    (42): e2106480118 DOI: 10.1073/pnas.2106480118 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/09/210929163800.htm

    --- up 3 weeks, 6 days, 8 hours, 25 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)